Picture of Eden Research logo

EDEN Eden Research News Story

0.000.00%
gb flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapSucker Stock

REG - Eden Research plc - Mevalone Organic Input Registration in Germany

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241211:nRSK5845Pa&default-theme=true

RNS Number : 5845P  Eden Research plc  11 December 2024

11 December 2024

 

 

Eden Research

("Eden" or "the Company")

 

 

Mevalone® included in Organic Input List by FiBL Germany

 

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and
biocontrol products, is pleased to announce that its flagship fungicide,
Mevalone®, has been registered as an input for organic farming in Germany.

 

The Input List for organic production in Germany is managed by the Research
Institute of Organic Agriculture, FiBL, a European organisation with presence
in several countries and with well-recognised and respected activities related
to sustainability and organic farming. This inclusion has been granted by
experts who evaluate farming inputs for their compliance with the requirements
of organic production in Germany and multiple other countries.

 

The news follows the approval of Mevalone in Germany, announced in August
2024. Eden's German commercial partner, Sumi Agro Deutschland, which has a
strong focus on supporting organic farmers, has reinforced the importance of
having this registration by FiBL Germany to better address the needs of
organic growers in Germany.

 

The registration for organic farming follows the German 2030 Organic Strategy
that was released in November 2023. The German 2030 Organic Strategy,
developed by the Federal Ministry of Food and Agriculture, outlines 30
measures the country will take with the aim of reaching 30% of organic
farmland in Germany by 2030(1). This policy exceeds the 25% of organic
farmland in the EU as set in the EU Green Deal and means that significant
action is required by the entire agriculture sector to reach this goal.
Therefore, the registration of Mevalone as an input for organic farming in
Germany positions the product as a significant contributor to support German
farmers to achieve their targets whilst also retaining productivity.

 

With FiBL Germany's addition of Mevalone to the Organic Input list, Eden
expects its flagship fungicide to become an even more versatile product used
by German organic growers to effectively control fungal diseases and to avoid
production loss, whilst also remaining consistent with the requirements of
organic agriculture.

 

Sean Smith, Chief Executive Officer of Eden Research plc, commented:

 

"Mevalone's inclusion in the Organic Input List by FiBL Germany provides us
with another vital organic registration in an important market, following in
the footsteps of Greece, Italy, and France.  Our products' organic compliance
demonstrates their sustainable qualities based on Eden's terpene chemistry, as
well as their strong efficacy, even when compared with conventional
pesticides.

 

"Germany currently has approximately 10% of apple orchards and 15% of vineyard
areas dedicated to organic farming, and indications show that these
proportions of organic farmland are growing rapidly. Against this backdrop, we
have strategically positioned Mevalone as one of the leading alternative
fungicide products that fits both the conventional and organic farming needs."

 

(1)Federal Ministry of Food and Agriculture: 2030 Organic Strategy - National
Strategy for 30 % Organic Food and Farming by 2030,
https://www.bmel.de/EN/topics/farming/organic-farming/2030-organic-strategy.html
(https://www.bmel.de/EN/topics/farming/organic-farming/2030-organic-strategy.html)
)

 

- ENDS -

 

 

For further information contact:

 

 Eden Research plc                                                 www.edenresearch.com (http://www.edenresearch.com/)
 Sean Smith                                                        01285 359 555

Alex Abrey

 Cavendish Capital Markets Limited (Nominated advisor and broker)
 Giles Balleny / George Lawson (Corporate Finance)                 020 7397 8900

 Charlie Combe (Broking)

Michael Johnson (Sales)

 Hawthorn Advisors (Financial PR)
 Victoria Ainsworth                                                eden@hawthornadvisors.com (mailto:eden@hawthornadvisors.com)

 

 

Notes to Editors:

 

Eden Research is the only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative biopesticide
products and natural microencapsulation technologies to the global crop
protection, animal health and consumer products industries.

 

Eden's products are formulated with terpene active ingredients, based on
natural plant defence metabolites. To date, they have been primarily used on
high-value fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional pesticides.
Eden has three products currently on the market:

 

Based on plant-derived active ingredients, Mevalone® is a foliar
biofungicide which initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops.  It is a useful tool in crop defence
programmes and is aligned with the requirements of integrated pest management
programmes. It is approved for sale in a number of key countries whilst Eden
and its partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.

 

Cedroz™( )is a bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and vegetable
crops globally.  Cedroz is registered for sale on two continents and Eden's
commercial collaborator, Eastman Chemical, is pursuing registration and
commercialisation of this important new product in numerous countries
globally.

 

Eden's seed treatment product, EcovelexÔ was developed to safely tackle
crop destruction caused by birds - a major cause of losses in maize and other
crops. Ecovelex works by creating an unpleasant taste or odour that repels
birds, leaving the seeds safely intact and the birds unaffected and free to
find alternative food sources. The product is based on Eden's plant-derived
chemistry, registered in the EU, U.S. and elsewhere, and formulated using
Eden's Sustaine® microencapsulation system.

 

Eden's Sustaine(®)( )encapsulation technology is used to harness the
biocidal efficacy of naturally occurring chemicals produced by plants
(terpenes) and can also be used with both natural and synthetic compounds to
enhance their performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres derived from
yeast. It is one of the only viable, proven and immediately registerable
solutions to the microplastics problem in formulations requiring
encapsulation.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the
symbol EDEN. It was awarded the London Stock Exchange Green Economy
Mark in January 2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services that
contribute to the global green economy. Eden derives 100% of its total annual
revenues from sustainable products and services.

 

For more information about Eden, please visit:  www.edenresearch.com
(http://www.edenresearch.com/) .

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  REAFFIFASELSEEE

Recent news on Eden Research

See all news